Combination of temsirolimus (CCI-779) with chemo-radiation in newly diagnosed GBM (NCCTG trial N027D) is associated with increased infectious risks1
- Citation:
- Clin Cancer Res vol 16 (22) 5573-5580
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Grants:
- U10 CA025224-25, P50 CA108961-019004, U24 CA114740-03, P50 CA108961, U10 CA025224-30S2, U10 CA025224-24S2, U10 CA025224-220017, U10 CA025224-23S1, U10 CA025224-30, U24 CA114740-04, U24 CA114740-05, U10 CA025224-28, U10 CA025224-31S1, U10 CA025224-23S10004, U24 CA114740, U24 CA114740-01, P50 CA108961-039004, CA-114740, CA-25224, U10 CA025224-28S3, U10 CA025224-29, U10 CA025224-30S3, U10 CA025224-24, U10 CA025224-28S1, U10 CA025224-31, CA-108961, U10 CA025224-27, P50 CA108961-049004, P50 CA108961-050001, P50 CA108961-010001, U10 CA025224-230004, U10 CA025224-32, P50 CA108961-029004, P50 CA108961-059004, U10 CA025224-23, P50 CA108961-020001, U10 CA025224-24S1, U10 CA025224-28S2, U24 CA114740-02, U10 CA025224-23S10017, U10 CA025224-220004, U10 CA025224, P50 CA108961-030001, P50 CA108961-040001, U24 CA114740-05S1, U10 CA025224-26, U10 CA025224-230017
- Corr. Author:
- Authors:
- Jann N. Sarkaria Eva Galanis Wenting Wu Allan B. Dietz Timothy J. Kaufmann Michael P. Gustafson Paul D. Brown Joon H. Uhm Ravi D. Rao Laurence Doyle Caterina Giannini Kurt A. Jaeckle Jan C. Buckner
- Networks:
- Study
- NCCTG-N027D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords:
- glioblastoma, immunosuppression, temsirolimus, radiation temozolomide, infection